This post has been archived and contains information that may be out of date.
CHA has issued a members-only summary, prepared by Health Policy Alternatives, Inc., of a proposed rule to implement policies in the Medicaid Drug Rebate Program related to legislative requirements addressing drug misclassification, as well as drug pricing and product data misreporting by manufacturers. The proposed rule also includes several other program integrity and program administration...
This content is restricted to members.
